233 related articles for article (PubMed ID: 8635041)
1. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute.
Zippin C; Lum D; Hankey BF
Cancer; 1995 Dec; 76(11):2343-50. PubMed ID: 8635041
[TBL] [Abstract][Full Text] [Related]
2. Study of completeness of the surveillance, epidemiology and end results (SEER) program case ascertainment by hospital size and casefinding source.
Zippin C; Lum D
Health Rep; 1993; 5(1):87-90. PubMed ID: 8334243
[TBL] [Abstract][Full Text] [Related]
3. Case-Completeness of Nonmalignant Central Nervous System Tumors in the Canadian Cancer Registry, 2011-2015.
Zakaria D; Shaw A; Woods R; De P; Davis F
J Registry Manag; 2018; 45(1):117-131. PubMed ID: 31017881
[TBL] [Abstract][Full Text] [Related]
4. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
Kim HM; Goodman M; Kim BI; Ward KC
J Registry Manag; 2011; 38(3):120-31. PubMed ID: 22223054
[TBL] [Abstract][Full Text] [Related]
5. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
6. Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data.
Wang Y; Sharpe-Stimac M; Cross PK; Druschel CM; Hwang SA
Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):663-8. PubMed ID: 16240383
[TBL] [Abstract][Full Text] [Related]
7. Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).
Ostrom QT; Gittleman H; Kruchko C; Louis DN; Brat DJ; Gilbert MR; Petkov VI; Barnholtz-Sloan JS
J Neurooncol; 2016 Oct; 130(1):31-42. PubMed ID: 27418206
[TBL] [Abstract][Full Text] [Related]
8. Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).
Wingo PA; Jamison PM; Hiatt RA; Weir HK; Gargiullo PM; Hutton M; Lee NC; Hall HI
Cancer Causes Control; 2003 Mar; 14(2):175-93. PubMed ID: 12749723
[TBL] [Abstract][Full Text] [Related]
9. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
[TBL] [Abstract][Full Text] [Related]
10. Reporting cutaneous melanoma to cancer registries in the United States.
Hall HI; Jamison P; Fulton JP; Clutter G; Roffers S; Parrish P
J Am Acad Dermatol; 2003 Oct; 49(4):624-30. PubMed ID: 14512907
[TBL] [Abstract][Full Text] [Related]
11. Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008.
Wilson RJ; O'Neil ME; Ntekop E; Zhang K; Ren Y
J Registry Manag; 2014; 41(2):65-71; quiz 96-7. PubMed ID: 25153011
[TBL] [Abstract][Full Text] [Related]
12. Using hospital medical record data to assess the accuracy of the SEER Los Angeles Cancer Surveillance Program for initial treatment of prostate cancer: a small pilot study.
Kraus RD; Hamilton AS; Carlos M; Ballas LK
Cancer Causes Control; 2018 Sep; 29(9):815-821. PubMed ID: 30022335
[TBL] [Abstract][Full Text] [Related]
13. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
14. An Assessment of the Completeness and Timeliness of the Israel National Cancer Registry.
Moore E; Silverman BG; Fishler Y; Ben-Adiva E; Davidov O; Dichtiar R; Edri H; Zatlawi M; Keinan-Boker L
Isr Med Assoc J; 2021 Jan; 23(1):23-27. PubMed ID: 33443338
[TBL] [Abstract][Full Text] [Related]
15. Using hospital discharge files to enhance cancer surveillance.
Penberthy L; McClish D; Pugh A; Smith W; Manning C; Retchin S
Am J Epidemiol; 2003 Jul; 158(1):27-34. PubMed ID: 12835284
[TBL] [Abstract][Full Text] [Related]
16. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
17. The National Cancer Data Base report on patterns of childhood cancers in the United States.
Grovas A; Fremgen A; Rauck A; Ruymann FB; Hutchinson CL; Winchester DP; Menck HR
Cancer; 1997 Dec; 80(12):2321-32. PubMed ID: 9404710
[TBL] [Abstract][Full Text] [Related]
18. SEER and NAACCR data completeness methods: how do they impact data quality in Central Cancer Registries?
Hwang LJ; Altekruse S; Adamo M; Sun L
J Registry Manag; 2012; 39(4):185-6. PubMed ID: 23493025
[TBL] [Abstract][Full Text] [Related]
19. Hospital discharge data: can it serve as the sole source of case ascertainment for population-based birth defects surveillance programs?
Wang Y; Cross PK; Druschel CM
J Public Health Manag Pract; 2010; 16(3):245-51. PubMed ID: 20357611
[TBL] [Abstract][Full Text] [Related]
20. Studying radiation therapy using SEER-Medicare-linked data.
Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
